MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3034% below fair value
$3.18+0.00 (0.00%)
Close on Nov 18, 2026Market cap $464.04MP/E –Yield –
MiMedx revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
MiMedx's revenue for the twelve months ending Sep 30, 2026 was $303.73M, down 22.8% year over year. For fiscal 2025 it was $418.63M, up 20.0% from the year before. Over ten years it grew 8.4% a year on average. The highest annual figure on record is $418.63M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $418.63M | +20.0% |
| FY2024 | Dec 31, 2024 | $348.88M | +8.5% |
| FY2023 | Dec 31, 2023 | $321.48M | +20.0% |
| FY2022 | Dec 31, 2022 | $267.84M | +10.7% |
| FY2021 | Dec 31, 2021 | $242.02M | -2.5% |
| FY2020 | Dec 31, 2020 | $248.23M | -17.0% |
| FY2019 | Dec 31, 2019 | $299.26M | -16.7% |
| FY2018 | Dec 31, 2018 | $359.11M | +11.8% |
| FY2017 | Dec 31, 2017 | $321.14M | +44.8% |
| FY2016 | Dec 31, 2016 | $221.71M | +18.4% |
| FY2015 | Dec 31, 2015 | $187.30M | +58.4% |
| FY2014 | Dec 31, 2014 | $118.22M | +99.8% |
| FY2013 | Dec 31, 2013 | $59.18M | +118.8% |
| FY2012 | Dec 31, 2012 | $27.05M | +248.6% |
| FY2011 | Dec 31, 2011 | $7.76M | +883.7% |
| FY2010 | Dec 31, 2010 | $788.87K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $62.28M | -45.2% |
| Q2 FY2026 | Jun 30, 2026 | $64.36M | -34.7% |
| Q1 FY2026 | Mar 31, 2026 | $58.99M | -33.1% |
| Q4 FY2025 | Dec 31, 2025 | $118.10M | +27.1% |
| Q3 FY2025 | Sep 30, 2025 | $113.73M | +35.3% |
| Q2 FY2025 | Jun 30, 2025 | $98.61M | +13.1% |
| Q1 FY2025 | Mar 31, 2025 | $88.21M | +4.1% |
| Q4 FY2024 | Dec 31, 2024 | $92.91M | +7.0% |
| Q3 FY2024 | Sep 30, 2024 | $84.06M | +2.9% |
| Q2 FY2024 | Jun 30, 2024 | $87.21M | +7.3% |
| Q1 FY2024 | Mar 31, 2024 | $84.71M | +18.2% |
| Q4 FY2023 | Dec 31, 2023 | $86.83M | +16.7% |
| Q3 FY2023 | Sep 30, 2023 | $81.71M | +20.7% |
| Q2 FY2023 | Jun 30, 2023 | $81.26M | +21.5% |
| Q1 FY2023 | Mar 31, 2023 | $71.68M | +21.7% |
| Q4 FY2022 | Dec 31, 2022 | $74.38M | +46.4% |
| Q3 FY2022 | Sep 30, 2022 | $67.69M | +7.3% |
| Q2 FY2022 | Jun 30, 2022 | $66.88M | -1.9% |
| Q1 FY2022 | Mar 31, 2022 | $58.89M | -1.8% |
| Q4 FY2021 | Dec 31, 2021 | $50.81M | -25.9% |
| Q3 FY2021 | Sep 30, 2021 | $63.07M | -1.9% |
| Q2 FY2021 | Jun 30, 2021 | $68.17M | +27.1% |
| Q1 FY2021 | Mar 31, 2021 | $59.97M | -2.9% |
| Q4 FY2020 | Dec 31, 2020 | $68.55M | -10.3% |
| Q3 FY2020 | Sep 30, 2020 | $64.30M | -27.6% |
| Q2 FY2020 | Jun 30, 2020 | $53.65M | -20.4% |
| Q1 FY2020 | Mar 31, 2020 | $61.74M | -7.2% |
| Q4 FY2019 | Dec 31, 2019 | $76.40M | -17.5% |
| Q3 FY2019 | Sep 30, 2019 | $88.86M | +2.2% |
| Q2 FY2019 | Jun 30, 2019 | $67.44M | -29.3% |
| Q1 FY2019 | Mar 31, 2019 | $66.56M | -20.9% |
| Q4 FY2018 | Dec 31, 2018 | $92.59M | +5.4% |
| Q3 FY2018 | Sep 30, 2018 | $86.96M | +3.5% |
| Q2 FY2018 | Jun 30, 2018 | $95.42M | +18.5% |
| Q1 FY2018 | Mar 31, 2018 | $84.15M | +22.3% |
| Q4 FY2017 | Dec 31, 2017 | $87.86M | +25.7% |
| Q3 FY2017 | Sep 30, 2017 | $84.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $80.49M | – |
| Q1 FY2017 | Mar 31, 2017 | $68.80M | – |
| Q4 FY2016 | Dec 31, 2016 | $69.88M | – |
See a number that looks wrong?